Home › Overweight › Florida
Overweight clinical trials in Florida
53 studies for Overweight are looking for participants at sites in Florida.
Cities in Florida
- Orlando25 studies
- Miami23 studies
- Jacksonville18 studies
- Deltona9 studies
- West Palm Beach9 studies
- Hialeah9 studies
- The Villages8 studies
- St. Petersburg7 studies
- Boca Raton7 studies
- Pembroke Pines6 studies
- Tampa6 studies
- Davie6 studies
- Ocala6 studies
- Hollywood5 studies
- Clearwater5 studies
- Pensacola4 studies
- Coral Springs4 studies
- Kendall4 studies
- Miramar4 studies
- Leesburg4 studies
- Naples4 studies
- Sunrise4 studies
- Cape Coral3 studies
- Town 'n' Country3 studies
- Gainesville3 studies
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Encore Medical Research LLC, Hollywood
- NextPhase Research, Hollywood
- Jacksonville Ctr Clin Res, Jacksonville
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Excel Medical Clinical Trials, Boca Raton
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Brain Matters Research, Delray Beach
- Northeast Research Institute, Fleming Island
- Miguel Rebollar PA, Hialeah
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07720271Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Clinical Pharmacology of Miami, Miami
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07399678Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Clinical Neuroscience Solutions, Orlando
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07837973Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Innovative Research of West Florida /ID# 281963, Clearwater
- Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
- Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979, Lake Worth
- and 8 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07752979A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- William A. Shands Hospital at the University of Florida, Gainesville
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- and 1 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- and 3 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- and 3 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
- Clinical Pharmacology of Miami, Miami
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 23, 2026 · NCT07803744A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- JEM Research Institute, Atlantis
- BioMed Research & Medical Center, Miami
- Adult Medicine of Lake County, Inc., Mt. Dora
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Excel Medical Clinical Trials, Boca Raton
- Velocity Clinical Research - New Smyrna Beach, Edgewater
- Alliance for Multispecialty Research - Fort Myers, Fort Myers
- and 20 more
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Coral Gables
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
- Emerald Coast Neurology - Airport Boulevard, Pensacola
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- JEM Research Institute, Atlantis
- AMR Clinical, Doral
- Northeast Research Institute (NERI), Fleming Island
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Westside Center for Clinical Research, Jacksonville
- Care Access - St. Petersburg, St. Petersburg
- Conquest Research, Winter Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07353931A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Boca Raton
- AURORA-2 Clinical Site, Daytona Beach
- AURORA-2 Clinical Site, Jacksonville
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Boca Raton
- AURORA-1 Clinical Site, Daytona Beach
- AURORA-1 Clinical Site, Jacksonville
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
- University of Central Florida, Orlando
Recruiting
Ages 5 to 11 · All sexes · Updated Sep 14, 2026 · NCT07464015A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- PharmaDev Clinical Research Institute LLC, Miami
- Essence MD Research, Naples
- Renstar Medical Research, Ocala
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07571005A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Clearwater
- ACCOMPLISH-2 Research Site, Fort Myers
- ACCOMPLISH-2 Research Site, Jacksonville
- and 5 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Sep 11, 2026 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- ERG Holding Company, LLC / Evolution Research Group, LLC, Delray Beach
- ERG Holding Company, LLC / Evolution Research Group, LLC, Fort Myers
- Jedidiah Clinical Research, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07770841AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- DM Clinical, Bradenton
- Essence MD Research, Naples
- Palm Beach Research Center, West Palm Beach
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07571109A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Precision Clinical Research, Sunrise
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07215559A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- NeoClinical Research, Hialeah
- Skin Care Research, Hollywood
- Encore Medical Research, Hollywood
- and 2 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06857942AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Northeast Research Institute, Fleming Island
- Jacksonville Ctr Clin Res, Jacksonville
- Florida Institute for Clinical Research, LLC, Orlando
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07533175Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Jacksonville Center for Clinical Research, Jacksonville
- Clinical Neuroscience Solutions - Jacksonville, Jacksonville
- South Florida Wellness and Clinical Research Institute, Margate
- and 8 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Bradenton
- Kailera Clinical Site, Hollywood
- Kailera Clinical Site, Jupiter
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Optimus U Corporation, Miami
- San Marcus Research Clinic Inc, Miami Lakes
- Indago Research and Health Center, Miami Lakes
- and 3 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Jupiter
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284875A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Encore Medical Research LLC, Hollywood
- Jacksonville Ctr for Clin Res, Jacksonville
- Encore Medical Research of Weston, Weston
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Aug 31, 2026 · NCT07253285Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- University of Florida Department of Medicine, Gainesville
- Aga Clinical Trials, Hialeah
- South Florida Clinical Research, Margate
- and 6 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Clearwater
- Research Site, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07784725From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.